Volume Alert - GSAT 2.83 Globalstar $GSAT Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GSAT 2.83 Globalstar $GSAT Hit a high today of 2.84 Closing the day 10:29 at 2.83 +0.08 +2.91% With a day low of 2.75 and a total volume of 1,392,935.

GSAT Recent Posts: http://investorshangout.com/Globalstar-Inc-GSAT-54279/

GSAT Globalstar Recent Headline News

One Reason Globalstar (GSAT) Stock Is Up Today
at The Street - Wed Nov 12, 12:21PM CST
Globalstar (GSAT) is gaining Wednesday after disclosing insider share purchases by the chairman and CEO, and a company director.
GSAT: 2.85 (+0.10)

Globalstar +4% on insider buys
Seeking Alpha - at Seeking Alpha - Wed Nov 12, 10:00AM CST

GSAT: 2.84 (+0.09)

Iridium Communications: Stock Reaching Critical Mass
Darspal S Mann - at Seeking Alpha - Wed Nov 12, 6:15AM CST

IRDM: 10.14 (+0.11), ORBC: 6.42 (-0.15), GSAT: 2.84 (+0.09)

InsiderInsights.com Daily Round Up 11/10/14: CHK, TWX, SGEN, PBFX
InsiderInsights - at Seeking Alpha - Tue Nov 11, 2:29AM CST

HAS: 54.70 (-2.77), VR: 40.00 (+0.21), SEIC: 39.57 (+0.10), DRNA: 9.31 (-0.22), HA: 18.04 (-0.17), SAM: 262.79 (-3.72), PBFX: 24.92 (-0.07), AMRI: 16.49 (-0.34), GSAT: 2.84 (+0.09), TNET: 31.96 (+0.65), TWX: 78.70 (+1.02), HLT: 25.14 (-0.18), Q: 56.50 (+0.09), SGEN: 37.18 (-0.62), CF: 266.07 (-0.31), OPK: 8.36 (-0.01), CHK: 22.64 (-0.77), CNDO: 1.81 (unch), CO: 4.87 (+0.02), CPLA: 69.26 (-0.85)

Globalstar: Evaluating Bankruptcy Risk
Richard Pearson - Seeking Alpha - Mon Nov 10, 8:30AM CST
Shares of Globalstar (NYSEMKT: GSAT ) have been on a roller coaster ride ever since Kerrisdale Capital presented a short thesis on the company in early October. The shares fell from just under $4.00 to as low as $1.56, before rebounding to the...
GSAT: 2.84 (+0.09)

Globalstar service revenue grows during past 3, 9 months
M2 - Mon Nov 10, 7:51AM CST
Globalstar, Inc. (NYSE: GSAT) today announced its financial results for the three- and nine-month periods ended September 30, 2014.
GSAT: 2.84 (+0.09)

WSJ: Elon Musk thinking of launching 700 Web satellites
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 1:12PM CST

LORL: 76.00 (-0.40), IRDM: 10.14 (+0.11), I: 17.92 (+0.15), GSAT: 2.84 (+0.09), VSAT: 65.85 (+1.84)

Globalstar's (GSAT) CEO Jay Monroe on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:37AM CST

GSAT: 2.84 (+0.09)

Globalstar closes up 5.7% following Q3 report
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:04PM CST

GSAT: 2.84 (+0.09)

Globalstar Announces Third Quarter 2014 Results
GlobeNewswire - Thu Nov 06, 4:24PM CST
Globalstar, Inc. (NYSE MKT:GSAT) today announced its financial results for the three and nine month periods ended September 30, 2014.
GSAT: 2.84 (+0.09)

Globalstar beats by $0.14, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:02PM CST

GSAT: 2.84 (+0.09)

After Recent Spike, Straight Path Could Fall 50%
Richard Pearson - Seeking Alpha - Tue Nov 04, 8:30AM CST
The recent travails of Globalstar Inc. (NYSEMKT: GSAT ) serve well to illustrate how retail-oriented stock promotions can achieve wildly overvalued share prices, until they are found out and come crashing back to earth. Prior to a report from...
IDT: 17.39 (+0.01), GNE: 6.61 (+0.03), STRP: 17.60 (-0.15), GSAT: 2.84 (+0.09)

Globalstar, Inc. Third Quarter 2014 Earnings Call Release Notice
GlobeNewswire - Mon Nov 03, 3:05PM CST
Globalstar, Inc. (NYSE MKT:GSAT) will announce its third quarter 2014 financial results on Thursday, November 6, 2014 after the market's close. The Company will conduct an earnings conference call that evening at 5:00 p.m. Eastern Time to discuss third quarter 2014 results.
GSAT: 2.84 (+0.09)

XNPT, AMRS, GSAT, CRDC, IOSP, OKS Expected To Be Down After Next Earnings Releases
M2 - Mon Nov 03, 3:33AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, November 4th 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and December earnings reports. Xenoport Inc (NASDAQ:XNPT), AMYRIS INC (NASDAQ:AMRS), Globalstar Inc (OTC:GSAT), Cardica Inc (NASDAQ:CRDC), INNOSPEC INC. (NASDAQ:IOSP), ONEOK PARTNERS, L.P. (NYSE:OKS) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Tuesday:
AMRS: 2.90 (-0.03), IOSP: 43.97 (-0.26), OKE: 55.77 (-0.69), CRDC: 0.85 (-0.02), OKS: 48.03 (+0.05), GSAT: 2.84 (+0.09), XNPT: 8.18 (+0.31)

After Hour Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 4:39PM CDT

FRM: 6.33 (-0.26), TTMI: 6.74 (-0.19), EGO: 5.88 (+0.13), AMBR: 11.46 (+0.09), BDBD: 9.58 (+0.28), DUST: 35.04 (+0.43), BZH: 18.65 (+0.03), ARNA: 4.74 (+0.04), GSAT: 2.84 (+0.09), CTCT: 34.77 (-0.23)

Globalstar: Elements Of Promotion
Richard Pearson - Seeking Alpha - Thu Oct 30, 9:00AM CDT
A few weeks ago, Kerrisdale Capital gave a presentation delivering its short thesis on Globalstar Inc. (NYSEMKT: GSAT ). Prior to rumors of Kerrisdale's presentation , Globalstar had been trading at close to $4.00, with a market cap of nearly $4...
NEON: 2.12 (-0.03), UNXL: 5.38 (+0.02), GSAT: 2.84 (+0.09)

Alternative Carriers Stocks Under Review - tw telecom, Vonage Holdings, Globalstar, Level 3 Communications, and 8x8
PR Newswire - Wed Oct 29, 8:20AM CDT
Investor-Edge has initiated coverage on the following equities: tw telecom inc. (NASDAQ: TWTC), Vonage Holdings Corporation (NYSE: VG), Globalstar Inc. (NYSE MKT: GSAT), Level 3 Communications Inc. (NYSE: LVLT), and 8x8 Inc. (NASDAQ: EGHT). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 28, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,005.75, up 1.12% and the NASDAQ Composite closed at 4,564.29, up 1.75%. The S&P 500 finished the session 1.19% higher at 1,985.05. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Telecommunication Services Sector Index ended the day at 159.20, up 0.95%, with the index advancing 2.82% in the previous three trading sessions. Register for your complimentary reports on these five stocks at:
LVLT: 48.30 (+1.08), TWTC: 42.78 (+1.01), GSAT: 2.84 (+0.09), EGHT: 7.95 (-0.01), VG: 3.72 (-0.02)

Globalstar: A Review Of The Experimental Licenses For TLPS
Kerrisdale Capital Management - Seeking Alpha - Tue Oct 28, 8:00AM CDT
Recently, Globalstar Inc. (NYSEMKT: GSAT ) applied to the FCC for a new experimental license to test its Terrestrial Low Power Service (TLPS) concept in California. Though the initial irrational enthusiasm over this relatively unimportant piece of...
GSAT: 2.84 (+0.09)

Ontario Federation of Snowmobile Clubs (OFSC) Selects Globalstar GPS Satellite Technology for Groomer Fleet Tracking
Marketwire Canada - Wed Oct 22, 7:00AM CDT
Editors Note: There is a photo associated with this press release.
GSAT: 2.84 (+0.09)

Globalstar Reiterates Value of Spectrum Assets
GlobeNewswire - Mon Oct 20, 4:48PM CDT
Globalstar, Inc. (NYSE:GSAT) today issued the following statement in response to Kerrisdale Capital's latest misguided attempt to manipulate the Company's stock price:
GSAT: 2.84 (+0.09)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles